DrugPatentWatch Database Preview
Details for Patent: 7,341,744
Which drugs does patent 7,341,744 protect, and when does it expire?
Patent 7,341,744 protects MYTESI and is included in one NDA.
This patent has nineteen patent family members in thirteen countries.
Summary for Patent: 7,341,744
| Title: | Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer |
| Abstract: | Pharmaceutical compositions containing a proanthocyanidin polymer composition which are useful for the treatment and prevention of secretory diarrhea are provided. The invention specifically relates to pharmaceutical formulations of a proanthocyanidin polymer composition which has been isolated from a Croton spp. or a Calophyllum spp. In particular, the invention relates to a formulation of a proanthocyanidin polymer composition which protects the composition from the effects of stomach acid after oral administration, particularly to those formulations which are enteric coated. The invention also relates to methods of producing a directly compressible proanthocyanidin polymer composition, as well as compositions containing the directly compressible proanthocyanidin polymer composition. |
| Inventor(s): | Rozhon; Edward James (El Granada, CA), Khandwala; Atul S. (San Carlos, CA), Sabouni; Akram (Fairport, NY), Balwani; Gul P. (Fremont, CA), Chan; Jody Wai-Han (Mountain View, CA), Sesin; David F. (San Carlos, CA) |
| Assignee: | Napo Pharmaceuticals, Inc. (South San Francisco, CA) |
| Application Number: | 09/712,033 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,341,744 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 7,341,744
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Y | SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,341,744
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 430477 | Start Trial | |||
| Australia | 2030302 | Start Trial | |||
| Australia | 4988197 | Start Trial | |||
| Australia | 775330 | Start Trial | |||
| Canada | 2269078 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
